C2 monitoring and absorption profiling of cyclosporine for optimization of immunosuppressive therapy in pediatric renal transplant recipients

Transplantation Proceedings

Volumn 35, Issue 6, 2003, Pages 2128-2130

  Weber, L T ^a   Shipkova, M ^a   Armstrong, V W ^a   Mehls, O ^a   Oellerich, M ^a   Tonshoff B ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; AREA UNDER THE CURVE; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG MONITORING; EVALUATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LONGITUDINAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RECIPIENT; RISK; ARTICLE; BLOOD; CLINICAL TRIAL; GRAFT REJECTION; IMMUNOLOGY; INTESTINE ABSORPTION; KIDNEY TRANSPLANTATION; METHODOLOGY; PRESCHOOL CHILD; REGRESSION ANALYSIS;

ADOLESCENT; AREA UNDER CURVE; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG MONITORING; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL ABSORPTION; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; REGRESSION ANALYSIS;

EID: 0141727495     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00743-7     Document Type: Conference Paper

References (6)

1. Oellerich M., Armstrong V.W. Ther Drug Monit. 24:2002;40.
2. Levy G.A. BioDrugs. 15:2001;279.
3. Barama A., Perner F., Beauregard-Zollinger L., et al. Transplantation. 69:2000;S162.
4. Belitsky P., Dunn S., Johnston A., et al. Clin Pharmacokinet. 39:2000;117.
5. Mahalati K., Belitsky P., West K., et al. J Am Soc Nephrol. 12:2001;823.
6. Halloran P.F., Helms L.M., Kung L., et al. Transplantation. 68:1999;1356.